en · de · es · pt
cjc-1295-notes.peptides3081.com › Wiki › Persistence, Stability And Measurement — Research Overview

Persistence, Stability And Measurement — Research Overview

By Editorial Desk · published 2026-02-27 · last reviewed 2026-04-07 · Wiki

Everything below concerns RP-HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-04-07. Numbers and descriptions here follow the published literature rather than marketing material.

Persistence, Stability and Measurement

The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.

Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.

Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.

Analytical Measurement And Stability

Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.

Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.

Cjc-1295 at a glance

PropertyValueNotes
Molecular massApproximately 3.4 to 3.6 kDaDepends on whether the affinity complex is attached
AppearanceWhite to off-white lyophilized powderFreeze-dried solid, often in a sealed vial
SolubilitySoluble in water and aqueous buffersDissolution rate varies with pH and buffer salt
Typical storageBelow minus 20 degrees Celsius, dry and darkDissolved material is usually kept cold and used promptly
Common analytical methodsReversed-phase HPLC and mass spectrometryPeptide mapping and amino acid analysis add sequence detail

Handling Storage and Quality Control

Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.

Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.

Related pages on this site

Background and Naming Conventions

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.

The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.

Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.

Compound Identity and Development History

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.

Supporting material

=== Positive symptoms === Positive symptoms are those for which function is gained: paresthesias, increased sensitivity, pain, muscle spasms, fasciculations. The symptoms represent hyperexcitability of a nerve where a signal is sent along a nerve due to a lower threshold for activation resulting in spontaneous signals. Demyelination can cause positive sensory symptoms such as pain due to increased ectopic firing. Demyelinated nerve tissue has been found to have a lower activation threshold for sending a signal, specifically for mechanosensitivity (e.g. light touch). While is some debate about the role of central nervous system sensitization in painful entrapment neuropathies, the success of peripheral nerve blocks suggests a peripheral nerve origin of this neuropathic pain.

==== Other physical effects ==== The effects can also include loss of appetite, hyperactivity, dilated pupils, flushed skin, excessive sweating, increased movement, dry mouth and teeth grinding (potentially leading to condition informally known as meth mouth), headache, rapid breathing, high body temperature, diarrhea, constipation, blurred vision, dizziness, twitching, numbness, tremors, dry skin, acne, and pale appearance. Long-term methamphetamine abuse compounds these effects; xerodermia may lead to the development of sores on the skin, as well as compulsive scratching due to pruritis and/or formication. Numerous deaths related to methamphetamine overdoses have been reported. Additionally, "[p]ostmortem examinations of human tissues have linked use of the drug to diseases associated with aging, such as coronary atherosclerosis and pulmonary fibrosis", which may be caused "by a considerable rise in the formation of ceramides, pro-inflammatory molecules that can foster cell aging and death."

==== Chemistry ==== In organic chemistry, in situ refers to processes that take place within the reaction mixture without isolating intermediates. In one-pot synthetic sequences, for example, in situ work-up modifications allow multiple reaction steps to proceed within a single vessel, reducing personnel exposure to unstable or hazardous substances (such as azide intermediates), which may pose safety risks if isolated. Another example is the Corey–Chaykovsky reagent, a sulfur ylide generated in situ by deprotonating sulfonium halides with a strong base. This approach is used because unstabilized sulfur ylides are highly reactive; if isolated, they may decompose or lose reactivity. Consequently, their direct generation and use within the reaction mixture is more practical. Analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, Raman spectroscopy, and mass spectrometry facilitate real-time monitoring of in situ reactions. These methods detect short-lived substances that form during a reaction, such as intermediates that might not be stable enough to isolate, and adjust conditions to improve the process; all without disturbing the reaction itself. In electrochemistry, in situ experiments are performed under the normal operating conditions of an electrochemical cell, with the electrode maintained at a controlled potential (typically by a potentiostat). By contrast, ex situ experiments occur outside those operating conditions, usually without potential control; for example, after the electrode has been removed from the cell or left at open-circuit.

Sources: en.wikipedia.org

Notes from published material

=== Liquid crystals === DSC is used in the study of liquid crystals. As some forms of matter go from solid to liquid they go through a third state, which displays properties of both phases. This anisotropic liquid is known as a liquid crystalline or mesomorphous state. Using DSC, it is possible to observe the small energy changes that occur as matter transitions from a solid to a liquid crystal and from a liquid crystal to an isotropic liquid.

Based on modeled and observed accumulated cyclone energy (ACE), El Niño years usually result in less active hurricane seasons in the Atlantic Ocean, but instead favor a shift to tropical cyclone activity in the Pacific Ocean, compared to La Niña years favoring above average hurricane development in the Atlantic and less so in the Pacific basin. Over the Atlantic Ocean, vertical wind shear is increased, which inhibits tropical cyclone genesis and intensification, by causing the westerly winds to be stronger. The atmosphere over the Atlantic Ocean can also be drier and more stable during El Niño events, which can inhibit tropical cyclone genesis and intensification. Within the Eastern Pacific basin: El Niño events contribute to decreased easterly vertical wind shear and favor above-normal hurricane activity. However, the impacts of the ENSO state in this region can vary and are strongly influenced by background climate patterns. The Western Pacific basin experiences a change in the location of where tropical cyclones form during El Niño events, with tropical cyclone formation shifting eastward, without a major change in how many develop each year. As a result of this change, Micronesia is more likely, and China less likely, to be affected by tropical cyclones. A change in the location of where tropical cyclones form also occurs within the Southern Pacific Ocean between 135°E and 120°W, with tropical cyclones more likely to occur within the Southern Pacific basin than the Australian region.

There are many reasons why an excited state can be metastable. The most common mechanism is by suppression of gamma decay of excited nuclei, making the decay route a forbidden transition. Spin is conserved, and a photon has spin 1 ħ. Thus, if a decay route would require a change of ≥ 2 ħ (any possible change is always integer) in angular momentum, then the gamma decay would become highly suppressed. For example, if the decay requires the nucleus to change spin by 2 ħ, then it must emit 2 photons at once. This is a 3-body interaction, which is much weaker than a 2-body interaction, and thus occurs at a much lower rate. In general, each additional unit of spin larger than 1 that the emitted gamma ray must carry inhibits decay rate by about 5 orders of magnitude. As the excited energy state lowers, eventually internal conversion (IC) and internal pair production (IP) takes over. The decay of 180mTa from spin-9 state to spin-2 state changes spin by 7 ħ. This suppresses the rate of gamma emission so much that the decay rate is essentially equal to the rate of IC, in agreement with the above. When the nucleus begins and ends with 0 spin, it cannot decay via single photo gamma emission. The only possible routes are IC, internal pair production, or two-photon gamma emission. Usually IC and IP dominates over two-photon gamma emission.

Taylor), in the grounds of their Oxford home (1946–47) before moving to a property she purchased in the Oxfordshire village of South Leigh (1947–49). In May 1949, the Thomas family moved back to Laugharne into The Boat House, purchased by Margaret Taylor on their behalf. In 1951 Taylor purchased a second property in Camden Town, North London on their behalf where they stayed from October 1951 – January 1952. Caitlin Thomas's autobiographies, Leftover Life to Kill (1957) and My Life with Dylan Thomas: Double Drink Story (1997), describe the effects of alcohol on their relationship: "Ours was not only a love story, it was a drink story, because without alcohol it would never had got on its rocking feet", she wrote, and "The bar was our altar." Biographer Andrew Lycett describes the relationship as one of alcoholic co-dependency and notes how deeply Caitlin resented her husband's numerous extramarital affairs. Dylan and Caitlin Thomas had three children: Llewelyn Edouard (1939–2000), Aeronwy Thomas-Ellis (1943–2009) and Colm Garan Hart (1949–2012). Llewelyn and Aeronwy were privately educated, at the Magdalen College School, Oxford and at the Arts Education School in Tring, Hertfordshire, respectively.

Sources: en.wikipedia.org

Frequently asked questions

What is the difference between the forms with and without a drug affinity complex?

The version carrying the affinity complex bears a maleimide group that binds serum albumin, which extends its circulation time to several days. The version without it lacks this group and clears within roughly half an hour. The two are chemically related but behave very differently once in the body.

Is CJC-1295 the same as MOD GRF 1-29?

In common usage the name without the affinity complex is often equated with MOD GRF 1-29, a fragment carrying four stabilizing substitutions. Strictly speaking, the term originally referred to the albumin-binding version. The overlap in naming causes frequent ambiguity in both informal and technical writing.

How is the compound identified in a laboratory?

Reversed-phase chromatography separates the peptide from related impurities and yields a purity estimate. Mass spectrometry confirms the molecular mass and detects modifications such as oxidation. Sequence-level checks rely on peptide mapping or amino acid analysis when stronger confirmation is needed.

How are the two variants distinguished in a laboratory?

The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.

Network